4//SEC Filing
SEELEY BRUCE J. 4
Accession 0000891293-20-000019
CIK 0000891293other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 7:58 PM ET
Size
5.5 KB
Accession
0000891293-20-000019
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-qualified Stock Option
2020-03-11+330,000→ 330,000 totalExercise: $1.00Exp: 2030-03-11→ Common stock (330,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates. The stock option is also subject to stockholder approval of an increase in the share reserve under the 2017 Equity Incentive Plan of the Company, which approval must occur within one year from the grant date.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001474462
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 7:58 PM ET
- Size
- 5.5 KB